Evidence map›Paper›PMID 41498783›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2026

Near-Infrared Imaging Using a Cathepsin-Targeted, Quenched Activity-Based Probe Identifies Naturally Occurring Canine Appendicular Osteosarcoma.

Anna M Massie, Charles W Bradley, Wilfried Mai, June DiBona, Andrew Dunlap, Jennifer Huck, Maureen Griffin, Brian Flesner, Kenneth J Drobatz, Sunil Singhal and 1 more

Abstract read
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anna M MassieDepartment of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0002-0598-4200
Charles W BradleyDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0002-8594-5307
Wilfried MaiDepartment of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0001-9147-6079
June DiBonaDepartment of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0009-0009-8185-5409
Andrew DunlapDepartment of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0009-0005-7829-5253
Jennifer HuckDepartment of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0009-0005-5161-1332
Maureen GriffinDepartment of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0001-9714-1579
Brian FlesnerDepartment of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0002-2459-7054
Kenneth J DrobatzDepartment of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0009-0002-9284-8959
Sunil SinghalDepartment of Surgery, University of Pennsylvania School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0002-2413-7082
David HoltDepartment of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0002-8819-7738

Funding

UNIVERSITY OF PENNSYLVANIA CAN CTR SUPPORT GRANTP30CA016520 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Robert H. Vonderheide · 1985 to 2026
$222.3M
Shared Resource - Core A: Administrative CoreP01CA254859 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Sunil Singhal · 2022 to 2026
$10.0M
Short-term Training: students in health professional schoolsT35OD010919 · OD · UNIVERSITY OF PENNSYLVANIA · PI Michael Lee Atchison · 2012 to 2026
$1.8M
NCI NIH HHS P01 CA254859NCI NIH HHS P30 CA016520NIH HHS T35 OD010919ODCDC CDC HHS T35 OD010919University of Pennsylvania (Penn)
6 · The paper itself

Abstract

purposeOsteosarcoma is the most common primary malignancy of the skeleton. Despite advances in imaging modalities, neoadjuvant and adjuvant chemotherapy, and limb-sparing surgery over the past decades, there has been a general lack of improvement in survival rates. Tumor recurrence and metastases are associated with a worse prognosis, and complete tumor excision is critical. The use of real-time imaging could facilitate the acquisition of tumor-free surgical margins. Spontaneous osteosarcoma in dogs is an established translational model of human osteosarcoma. EXPERIMENTAL

designIn this study, 12 dogs with spontaneous appendicular osteosarcoma received a cathepsin-targeted quenched activity-based probe (VGT-309) intravenously 16 to 20 hours before amputation. The limb was imaged at four levels of dissection, and the margins of near-infrared fluorescence were marked for comparison with histopathology and preoperative MRI.

resultsAll appendicular tumors fluoresced on cross-section of the bone, and the extent of fluorescence coincided with MRI and histopathologic margins, with variability associated with necrosis. All tumors had visible fluorescence through cortical bone, although this did not consistently reflect intramedullary extension of the tumor. Necrotic tumor regions did not fluoresce.

conclusionsThese data support the safety and feasibility of VGT-309 as a tool for evaluating the tissue extent of canine osteosarcoma and spur investigation for intraoperative detection of osteosarcoma during limb-sparing surgery in humans. Due to frequent intramedullary tumor extension and inconsistent fluorescence through unaffected cortical bone, this modality is likely most appropriate for assessing residual tumor following planned resection. Caution should be exercised when significant tumor necrosis is present.

Indexed as

Bone NeoplasmsCathepsinsDog DiseasesOsteosarcomaAnimalsDogsFemaleFluorescent DyesHumansMagnetic Resonance ImagingSpectroscopy, Near-InfraredCathepsinsFluorescent Dyes

Identifiers

PMID41498783
PMCPMC12912045

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.